Monoamine-depleting drugs.
D012369:2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001679:Biogenic Amines / Q000096:biosynthesis / Q000378:metabolism*; D002490:Central Nervous System / Q000187:drug effects; D003864:Depression, Chemical; D004347:Drug Interactions; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009474:Neurons / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000031:analogs & derivatives / Q000494:pharmacology; D013268:Stimulation, Chemical; D013747:Tetrabenazine / Q000494:pharmacology; D013997:Time Factors
D001679:Biogenic Amines; D008996:Monoamine Oxidase Inhibitors; D012369:2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; D012110:Reserpine; D013747:Tetrabenazine